Fragen? Antworten! Siehe auch: Alternativlos
The approval paves the way for the launch of Natco's drug in the market, a company official told TOI, adding that it will pay a 6% royalty on net sales every quarter to Bayer. The licence will be valid till such time the drug's patent is valid, i.e. 2020. As per the CL (compulsory licence) order, Natco is also committed to donating free supplies of the medicines to 600 patients each year.Wieso macht Deutschland sowas eigentlich nicht?
Oh und noch ein Detail:
The patent office acted on the basis that not only had Bayer failed to price the drug at a level that made it accessible and affordable, it also was unable to ensure that the medicine was available in sufficient quantities within India.Da fehlt mir echt jede Grundlage für Mitleid.